Trial by Science
From foxglove to pharmacy: how a new drug is discovered, tested and trialled. Preclinical, clinical, placebo and double-blind.
Work it through together, step by step
A free interactive activity that works the method through with a class, step by step.
Start revising freeWhat you'll cover
Trial by Science
Before a new medicine reaches a pharmacy it faces years of testing, designed to answer two questions: is it **safe**, and does it **work**? Many drugs started out extracted from **plants and microorganisms**: • **Digitalis**: a heart drug from **foxgloves**. • **Aspirin**: a painkiller from **willow** bark. • **Penicillin**: the first antibiotic, discovered by **Alexander Fleming** from the **Penicillium mould**. This module follows a drug from its source through preclinical testing and human trials to approval.
Name the source
The antibiotic **penicillin** was originally discovered from what?
- A mould, discovered by Alexander Fleming
- The foxglove plant
- Willow bark
- An animal
Three questions
Every potential new drug is tested for three things, and the exam wants the term, not the paraphrase:
Match the terms
- Toxicity
- Efficacy
- Dose
- Is the drug harmful?
- Does the drug actually work?
- How much should be given?
Two stages of testing
Testing runs in two big stages, and a question naming one rarely wants the other. Safety always comes before dose: you never give a large dose until you know it is not toxic.
Order the testing
Put the stages of testing a new drug into the correct order, from first to last.
- Test on cells and tissues in the lab
- Test on live animals
- Test on healthy volunteers at a very low dose
- Test on patients to find the optimum dose
Removing bias
To trust the results, trials are designed to remove **bias**: • A **placebo** is a dummy treatment with no active drug. Some patients get it so the drug's effect can be compared fairly. • In a **double-blind** trial, **neither the patients nor the doctors** know who got the real drug. so expectations can't sway the result. • Finally, results are **peer reviewed**: checked by other scientists before publication. To catch false claims.
Who knows?
In a **double-blind** trial, who knows which patients are getting the real drug rather than the placebo?
- Neither the patients nor the doctors
- Only the doctors
- Only the patients
- Everyone is told
Complete the process
New drugs are first tested in the lab on cells, tissues and _____, then in clinical trials on human _____. To remove bias, trials are often _____.
True of clinical trials?
Pick the TWO correct statements about clinical trials.
- Healthy volunteers are tested first, at low doses, to check safety
- In a double-blind trial neither doctor nor patient knows who got the real drug
- New drugs skip lab testing and go straight to patients
- Patients are always told immediately if they got the placebo
Design the trial
A new drug has passed preclinical testing. You are designing the human trial. Make three decisions.
- Who receives the drug first, and at what dose?
- Half your patients improve. How do you show the drug caused it?
- Your doctors know which patients got the real drug, and you are worried it is colouring their assessments. What do you change?
Explain the order
Explain why a new drug is given to healthy volunteers at a very low dose before it is ever given to patients. Take the reasoning through to what would go wrong otherwise.
- Say which of the three questions the first stage is trying to answer
- Say why a low dose is used rather than the dose you hope will work
- Say what the risk would be if patients were given a full dose first
In the exam
Trial complete. Grade-9 habits for drug development: • Drugs are tested for **toxicity, efficacy and dose**: **safety first**, always. • **Preclinical** = cells, tissues, animals; **clinical** = healthy volunteers then patients. • **Placebo** and **double-blind** remove bias; **peer review** checks the results before they're published.